Pharmaceutical
| Mon 16 Feb 2026
Munich, Feb. 16 -- Eli Lilly and Company has submitted a patent application for KRAS Inhibitors. This invention was developed by Abraham Adedoyin David, Valero De La Cruz Alberto, Dilger Andrew, Bume Desta, Priego Soler Julián, Prieto Vallejo Maria Lourdes, Barberis Mario, Garzón Sanz Miguel, Rajamani Ramkumar, Aronow Sean, Wa..